FAUCI DIARY ARCHIVE — Monday, March 22, 2021
https://faucisdiary.com/diary/2021-03-22

Text below is verbatim from the released PDFs, with the original line breaks.
==============================================================================

DIARY ENTRY — Monday, March 22, 2021
Source: Tony's Diary Package, pp. 659–661 of 2026.07.24_Tonys-Diary-Package.pdf
Words: 429
------------------------------------------------------------------------------
Global -123,000,000/2,700,000; USA – 29,700,000/540,000
Trump has been attacking me (and Deb Birx) in recent interviews on FOX News and “the Hill”
(see below) saying that we were wrong most of the time. However, he actually says that I am a
nice guy and he likes me.
Big semi-scandal! AstraZeneca again messed up. Today was the day when they announced the
data of their phase three clinical trial of a covid vaccine. The data showed a 78.9% efficacy with
good efficacy against severe disease. They put out a press conference and press release and we
followed with a press release that mirrored their release. As it turns out the data and safety
monitoring board, which was getting impatient with them and was having trouble with their
submission from the beginning, send them a harsh letter also addressed to me indicating that the
data in their press release was not the most recent data an actually made the data looked more
favorable. When the White House found out about this, it triggered a series of zoom calls with
the comms team of the White House (Courtney Rowe et al) led by Jeff Zients. the final decision
was that we would put out a press statement from NIAID in the middle of the night urging AZ to
come clean with the DSMB and to straighten out their press release. See below the letter from
the DSMB to me and AZ as well as our press release.

              final Concern over
             AZ press release.pdf

                                          NIAID Statement on AstraZeneca Vaccine

Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by
information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial. The DSMB expressed concern that
AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy
data. We urge the company to work with the DSMB to review the efficacy data and ensure the most accurate, up-to-date efficacy
data be made public as quickly as possible.

Authorization and guidelines for use of the vaccine in the United States will be determined by the Food and Drug Administration
and Centers for Disease Control and Prevention after thorough review of the data by independent advisory committees.

PRESS: White House Press briefing – I presented the AZ results – 78.9% effective and
100% effective against sever disease – 0 in vaccine; 5 in placebo; BBC Radio World News;
The Hill:

Trump says Fauci 'a
promoter more than
anything'
BY JUSTINE COLEMAN - 03/22/21 09:18 AM EDT 621